Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 308

1.

Recruited T cells promote the bladder cancer metastasis via up-regulation of the estrogen receptor β/IL-1/c-MET signals.

Tao L, Qiu J, Slavin S, Ou Z, Liu Z, Ge J, Guancial EA, Messing EM, Chang C, Yeh S.

Cancer Lett. 2018 Apr 20. pii: S0304-3835(18)30248-9. doi: 10.1016/j.canlet.2018.03.045. [Epub ahead of print]

PMID:
29684419
2.

Molecular Landscape of Non-Muscle Invasive Bladder Cancer.

Messing EM.

Bladder Cancer. 2018 Jan 20;4(1):131-132. doi: 10.3233/BLC-189027. No abstract available.

3.

Characterization of urinary extracellular vesicle proteins in muscle-invasive bladder cancer.

Silvers CR, Miyamoto H, Messing EM, Netto GJ, Lee YF.

Oncotarget. 2017 Aug 8;8(53):91199-91208. doi: 10.18632/oncotarget.20043. eCollection 2017 Oct 31.

4.

Bladder Sparing Therapy for BCG Failures - I - Intravesical Immunotherapy.

Messing EM.

Bladder Cancer. 2017 Oct 27;3(4):313-314. doi: 10.3233/BLC-179023. No abstract available.

5.

Multi-institutional nomogram predicting benign prostate pathology on magnetic resonance/ultrasound fusion biopsy in men with a prior negative 12-core systematic biopsy.

Truong M, Wang B, Gordetsky JB, Nix JW, Frye TP, Messing EM, Thomas JV, Feng C, Rais-Bahrami S.

Cancer. 2018 Jan 15;124(2):278-285. doi: 10.1002/cncr.31051. Epub 2017 Oct 4.

PMID:
28976544
6.

Validation of GEMCaP as a DNA Based Biomarker to Predict Prostate Cancer Recurrence after Radical Prostatectomy.

Nguyen HG, Welty C, Lindquist K, Ngo V, Gilbert E, Bengtsson H, Magi-Galluzzi C, Jean-Gilles J, Yao J, Cooperberg M, Messing E, Klein EA, Carroll PR, Paris PL.

J Urol. 2017 Sep 20. pii: S0022-5347(17)77554-4. doi: 10.1016/j.juro.2017.09.071. [Epub ahead of print]

PMID:
28941923
7.

The BCG Shortage.

Messing EM.

Bladder Cancer. 2017 Jul 27;3(3):227-228. doi: 10.3233/BLC-179018. No abstract available.

8.

The role of urinary cytology when diagnostic workup is suspicious for upper tract urothelial carcinoma but tumour biopsy is nonconfirmatory.

Horovitz D, Meng Y, Joseph JV, Feng C, Wu G, Rashid H, Messing EM.

Can Urol Assoc J. 2017 Jul;11(7):E285-E290. doi: 10.5489/cuaj.4150. Epub 2017 Jul 11.

9.

Exploratory Subgroup Analyses of Renal Function and Overall Survival in European Organization for Research and Treatment of Cancer randomized trial of Nephron-sparing Surgery Versus Radical Nephrectomy.

Scosyrev E, Messing EM, Sylvester R, Van Poppel H.

Eur Urol Focus. 2017 Apr 4. pii: S2405-4569(17)30063-9. doi: 10.1016/j.euf.2017.02.015. [Epub ahead of print]

PMID:
28753863
10.

Rate of Symptomatic Lymphocele Formation After Extraperitoneal vs Transperitoneal Robot-Assisted Radical Prostatectomy and Bilateral Pelvic Lymphadenectomy.

Horovitz D, Lu X, Feng C, Messing EM, Joseph JV.

J Endourol. 2017 Oct;31(10):1037-1043. doi: 10.1089/end.2017.0153. Epub 2017 Aug 30.

PMID:
28741376
11.

A Comprehensive Analysis of Cribriform Morphology on Magnetic Resonance Imaging/Ultrasound Fusion Biopsy Correlated with Radical Prostatectomy Specimens.

Truong M, Feng C, Hollenberg G, Weinberg E, Messing EM, Miyamoto H, Frye TP.

J Urol. 2018 Jan;199(1):106-113. doi: 10.1016/j.juro.2017.07.037. Epub 2017 Jul 18. Erratum in: J Urol. 2017 Dec 8;:.

PMID:
28728994
12.

Retroperitoneal Lymphadenectomy for High Risk, Nonmetastatic Renal Cell Carcinoma: An Analysis of the ASSURE (ECOG-ACRIN 2805) Adjuvant Trial.

Ristau BT, Manola J, Haas NB, Heng DYC, Messing EM, Wood CG, Kane CJ, DiPaola RS, Uzzo RG.

J Urol. 2018 Jan;199(1):53-59. doi: 10.1016/j.juro.2017.07.042. Epub 2017 Jul 18.

PMID:
28728992
13.

Perineural invasion by prostate cancer on MR/US fusion targeted biopsy is associated with extraprostatic extension and early biochemical recurrence after radical prostatectomy.

Truong M, Rais-Bahrami S, Nix JW, Messing EM, Miyamoto H, Gordetsky JB.

Hum Pathol. 2017 Aug;66:206-211. doi: 10.1016/j.humpath.2017.06.017. Epub 2017 Jul 11.

PMID:
28705708
14.

Cautery artifact understages urothelial cancer at initial transurethral resection of large bladder tumours.

Truong M, Liang L, Kukreja J, O'Brien J, Jean-Gilles J, Messing E.

Can Urol Assoc J. 2017 May;11(5):E203-E206. doi: 10.5489/cuaj.4172. Epub 2017 May 9.

15.

Reduced estimated glomerular filtration rate (eGFR <60 mL/min/1.73 m2 ) at first transurethral resection of bladder tumour is a significant predictor of subsequent recurrence and progression.

Blute ML Jr, Kucherov V, Rushmer TJ, Damodaran S, Shi F, Abel EJ, Jarrard DF, Richards KA, Messing EM, Downs TM.

BJU Int. 2017 Sep;120(3):387-393. doi: 10.1111/bju.13904. Epub 2017 Jun 23.

PMID:
28464520
16.

Editorial Comment.

Messing EM.

J Urol. 2017 Feb;197(2):313. doi: 10.1016/j.juro.2016.08.134. Epub 2016 Oct 27. No abstract available.

PMID:
28346984
17.

Re: Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma.

Messing EM.

Eur Urol. 2017 Jul;72(1):153-154. doi: 10.1016/j.eururo.2017.02.035. Epub 2017 Mar 11. No abstract available.

PMID:
28292548
18.

Complete Remission of Locally Advanced Penile Squamous Cell Carcinoma after Multimodality Treatment.

Meng Y, Bernie HL, Weng TH, Ling DA, Messing EM, Guancial E.

Rare Tumors. 2016 Dec 20;8(4):6651. doi: 10.4081/rt.2016.6651. eCollection 2016 Nov 17.

19.

Impact of Gleason Subtype on Prostate Cancer Detection Using Multiparametric Magnetic Resonance Imaging: Correlation with Final Histopathology.

Truong M, Hollenberg G, Weinberg E, Messing EM, Miyamoto H, Frye TP.

J Urol. 2017 Aug;198(2):316-321. doi: 10.1016/j.juro.2017.01.077. Epub 2017 Feb 3.

PMID:
28163032
20.

A More Thorough Transurethral Resection.

Messing EM.

Bladder Cancer. 2017 Jan 27;3(1):75-77. doi: 10.3233/BLC-169014. No abstract available.

Supplemental Content

Loading ...
Support Center